Among the principal mediators of inflammation in RA, Prostaglandin E2 (PGE2) represents the target of non-steroidal anti-inflammatory drugs and selective cyclooxygenase-2 (COX2) inhibitors, such as celecoxib (29). The gene discussed is PTGS2; the disease is rheumatoid arthritis.